Drugs / Rocuroni
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT07558226 Comparator | May 2026 → Nov 2027 expected | — | Fundacio Puigvert | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rocuroni | “Rocuroni: 0.3mg/kg iv” NCT07558226 ↗ |
| Route | Intravenous | “Rocuroni: 0.3mg/kg iv” NCT07558226 ↗ |